financetom
Business
financetom
/
Business
/
Lower interest rate focus has been our game for MSMEs in India, says AB Sunlife AMC’s Balasubramanian
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lower interest rate focus has been our game for MSMEs in India, says AB Sunlife AMC’s Balasubramanian
Jul 29, 2021 7:02 AM

Aditya Birla Sunlife AMC has put out their annual trendspotting report where they highlight five big themes for the future. These are manufacturing, digitalisation, sustainability, real estate and the mid & small cap revival.

Share Market Live

NSE

Talking about manufacturing space, A Balasubramanian, MD & CEO of Aditya Birla Sun Life AMC, said, “Since the time Make in India, which gradually got reinforced as vocal for local, I think government of India and respective state governments were enabling such manufacturing to be undertaken in India is something we feel there is a continuous progress. Lower interest rates focus has been our game for MSMEs in India, this gave a huge benefit uplift for the Indian manufacturing companies.”

He added, “Global supply disruption is happening mainly because of China regulation becoming more and more stringent and most of the companies who had huge presence in China also started looking at an alternate to China as a next-best alternate that one can create for China manufacturing sectors and India is prominently figuring on the global radar.”

“Also, the government initiatives to provide all the support that is needed so that it can make at least the local companies or manufacturing companies, make the return on investment to become much better and more visible and that is something we believe that could potentially happen.”

Balasubramanian also added, “Manufacturing sector likely to contribute more to India’s GDP.”

Watch accompanying video for more.

(Edited by : Bivekananda Biswas)

First Published:Jul 29, 2021 4:02 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Oscar Health Misses Q3 Revenue, Loss Widens To $129 Million Despite Membership Surge
Oscar Health Misses Q3 Revenue, Loss Widens To $129 Million Despite Membership Surge
Nov 6, 2025
Oscar Health Inc. ( OSCR ) reported third-quarter revenue of approximately $2.99 billion, compared to $2.4 billion a year ago, missing the consensus estimate of $3.08 billion. • OSCR stock is building positive momentum. See the trading setup here. The increase was driven by higher membership, partially offset by an increase in the net risk adjustment transfer accrual. The health...
TransAlta to Appoint CFO Joel Hunter to CEO Role as Kousinioris Plans to Retire; Shares Down 15%
TransAlta to Appoint CFO Joel Hunter to CEO Role as Kousinioris Plans to Retire; Shares Down 15%
Nov 6, 2025
01:50 PM EST, 11/06/2025 (MT Newswires) -- TransAlta ( TAC ) on Thursday said Chief Financial Officer Joel Hunter will be promoted to the role of chief executive after John Kousinioris, its current CEO, retires effective April 30, 2026. Hunter be will be nominated to join the board effective April 30. Kousinioris agreed to serve as a strategic advisor to...
SupplyOne Acquires Lamb & Associates Packaging, Expanding Its Midwest Presence
SupplyOne Acquires Lamb & Associates Packaging, Expanding Its Midwest Presence
Nov 6, 2025
The Arkansas-based packaging provider also offers advanced digital printing, further enhancing SupplyOne Digital's printing and finishing capabilities. NEWTOWN SQUARE, Pa. , Nov. 6, 2025 /PRNewswire/ - SupplyOne, Inc., a leading distributor of custom corrugated and value-added packaging solutions in North America, has expanded its footprint in the Midwest by acquiring Lamb & Associates Packaging, Inc., a well‑established packaging manufacturer based in...
Evommune Shares Rise in NYSE Debut
Evommune Shares Rise in NYSE Debut
Nov 6, 2025
01:50 PM EST, 11/06/2025 (MT Newswires) -- Evommune ( EVMN ) shares rose 21% to $19.42 in their New York Stock Exchange debut on Thursday after the clinical-stage biotechnology company raised $150 million in an initial public offering. The offering of 9.4 million Class A shares was priced at $16 apiece. Underwriters have a 30-day option to purchase up to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved